At present, propranolol hydrochloride has become a first-line drug for the treatment of infantile hemangioma, which not only significantly improves the clinical efficacy of infantile hemangioma, but also reduces the adverse reactions caused by the use of laser, hormone and other treatments in the past, so it has been widely recognized by the medical community.
However, when using propranolol hydrochloride to treat hemangioma, hemangioma specialists at home and abroad found that although the drug is ideal for infantile hemangioma in the period of rapid growth, the effect of propranolol will gradually weaken if the growth rate of tumors in children decreases. Therefore, parents in the discovery of their baby’s hemangioma, it is best to carry out early intervention treatment.
For example, our team once treated a 3-month-old girl.
Because the hemangioma of the lip just belongs to the rapid growth period at the time of treatment, the tumor has shrunk to more than 50% of the original after 2 months of medication.
In contrast
, we also treated a child who had received oral propranolol treatment in another hospital, and it was because the best treatment opportunity was missed that the effect was not ideal.
Hemangioma Hemangioma in children
